Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

2(40.0%)

Phase 1

2(40.0%)

Phase 4

1(20.0%)

5Total

Phase 2(2)

Phase 1(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT00272714Phase 2Completed

Study of Afimoxifene Gel to Treat Cyclic Mastalgia in Premenopausal Women

Role: lead

NCT00160173Phase 4Completed

Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

Role: lead

NCT00163566Phase 2Completed

Study of DHT-Gel to Treat the Symptoms of Low Testosterone in Men 55-80

Role: lead

NCT00598247Phase 1Completed

A Pilot Study of PPX in Women With Metastatic Colorectal Cancer

Role: collaborator

NCT00490022Phase 1Completed

Effect of Dihydrotestosterone (DHT) on Prostate Tissue [Short Title: DHT-3]

Role: collaborator

All 5 trials loaded